These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1378925)

  • 21. The primary GP5 neutralization epitope of North American isolates of porcine reproductive and respiratory syndrome virus.
    Plagemann PG
    Vet Immunol Immunopathol; 2004 Dec; 102(3):263-75. PubMed ID: 15507310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope.
    Key G; Becker MH; Baron B; Duchrow M; Schlüter C; Flad HD; Gerdes J
    Lab Invest; 1993 Jun; 68(6):629-36. PubMed ID: 7685843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic structure and genetic mapping of the human neutral cysteine protease bleomycin hydrolase.
    Montoya SE; Ferrell RE; Lazo JS
    Cancer Res; 1997 Oct; 57(19):4191-5. PubMed ID: 9331073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on the mechanism of drug resistance in tumor cells and a new antitumor antibiotic].
    Tanaka N
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2666-73. PubMed ID: 6210060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cloning and expression analysis of human bleomycin hydrolase, a cysteine proteinase involved in chemotherapy resistance.
    Ferrando AA; Velasco G; Campo E; Lopez-Otin C
    Cancer Res; 1996 Apr; 56(8):1746-50. PubMed ID: 8620487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Separation of the protective enzyme bleomycin hydrolase from rabbit pulmonary aminopeptidases.
    Sebti SM; Lazo JS
    Biochemistry; 1987 Jan; 26(2):432-7. PubMed ID: 3103681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lidocaine potentiation of bleomycin A2 cytotoxicity and DNA strand breakage in L1210 and human A-253 cells.
    Lazo JS; Braun ID; Meandzija B; Kennedy KA; Pham ET; Smaldone LF
    Cancer Res; 1985 May; 45(5):2103-9. PubMed ID: 2580616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epitope mapping of two major inhalant allergens, Der p I and Der f I, from mites of the genus Dermatophagoides.
    Chapman MD; Heymann PW; Platts-Mills TA
    J Immunol; 1987 Sep; 139(5):1479-84. PubMed ID: 2442247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cysteine proteinase inhibitors and bleomycin-sensitive and -resistant cells.
    Morris G; Mistry JS; Jani JP; Sebti SM; Lazo JS
    Biochem Pharmacol; 1991 Jun; 41(11):1559-66. PubMed ID: 1710457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular degradation of bleomycin hydrolase in two Chinese hamster cell lines in relation to their peplomycin susceptibility.
    Nishimura C; Suzuki H; Tanaka N; Yamaguchi H
    Biochim Biophys Acta; 1989 Jun; 1012(1):29-35. PubMed ID: 2471552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Secondary Antibody-Detecting Molecular Weight Marker with Mouse and Rabbit IgG Fc Linear Epitopes for Western Blot Analysis.
    Lin WW; Chen IJ; Cheng TC; Tung YC; Chu PY; Chuang CH; Hsieh YC; Huang CC; Wang YT; Kao CH; Roffler SR; Cheng TL
    PLoS One; 2016; 11(8):e0160418. PubMed ID: 27494183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of bleomycin resistance in a human oral squamous carcinoma cell line and characterisation of bleomycin-resistant and -sensitive clones.
    Urade M; Ogura T; Uematsu T; Takahashi Y; Kishimoto H; Yoshioka W
    Eur J Cancer B Oral Oncol; 1994 Nov; 30B(6):409-14. PubMed ID: 7536509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activities of recombinant human bleomycin hydrolase on bleomycins and engineered analogues revealing new opportunities to overcome bleomycin-induced pulmonary toxicity.
    Crnovcic I; Gan F; Yang D; Dong LB; Schultz PG; Shen B
    Bioorg Med Chem Lett; 2018 Sep; 28(16):2670-2674. PubMed ID: 29730026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-performance liquid chromatography assay of bleomycin in human plasma and rat hepatocytes in culture.
    Mahdadi R; Kenani A; Pommery N; Pommery J; Hénichart JP; Lhermitte M
    Cancer Chemother Pharmacol; 1991; 28(1):22-6. PubMed ID: 1710176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigenic sites on mouse 2.5S nerve growth factor.
    Butler RH; Revoltella RP
    Mol Immunol; 1982 Feb; 19(2):323-7. PubMed ID: 6178958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total synthesis of deamido bleomycin a(2), the major catabolite of the antitumor agent bleomycin.
    Zou Y; Fahmi NE; Vialas C; Miller GM; Hecht SM
    J Am Chem Soc; 2002 Aug; 124(32):9476-88. PubMed ID: 12167044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The C-terminus of human bleomycin hydrolase is required for protection against bleomycin-induced chromosomal damage.
    Lefterov IM; Koldamova RP; King J; Lazo JS
    Mutat Res; 1998 Oct; 421(1):1-7. PubMed ID: 9748474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical and immunological characterization of the two alpha-N-acetylgalactosaminidases from squid liver.
    Sadik G; or Rashid MH; Itoh-Nashida T; Ishii K; Sato Y; Shiraishi T; Uda Y
    Biol Pharm Bull; 2009 Aug; 32(8):1469-72. PubMed ID: 19652392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversed-phase paired-ion high-performance liquid chromatographic method for the separation and quantification of multiple bleomycin congeners.
    Klett RP; Chovan JP; Danse IH
    J Chromatogr; 1984 Oct; 310(2):361-71. PubMed ID: 6210296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic inactivation of bleomycin analogs by bleomycin hydrolase.
    Sebti SM; Lazo JS
    Pharmacol Ther; 1988; 38(3):321-9. PubMed ID: 2461572
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.